Tighter glycaemic and BP control needed for young adults with T2DM: experts
New Australian consensus guidance calls for more aggressive intervention than previously recommended for people under 30
Young adults with type 2 diabetes should ideally be treated to a “more stringent” glycated haemoglobin target of 6.5% or under, according to the first guidance for this age group.
SGLT2 inhibitors and GLP-1 receptor agonists can also be prescribed for affected patients aged 18-30 years given their elevated risk of cardiovascular and renal complications, clinicians say.
